Trials / Completed
CompletedNCT02319941
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes
Comparison of Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients With Acute Coronary Syndromes; Pharmacodynamics and Pharmacokinetics Study
- Status
- Completed
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 65 (actual)
- Sponsor
- Seung-Jung Park · Academic / Other
- Sex
- All
- Age
- 20 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to compare Low-Dose, Standard-Dose Ticagrelor and Clopidogrel for Inhibition of Platelet Reactivity in Patients with Acute Coronary Syndromes
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | ticagrelor | |
| DRUG | clopidogrel |
Timeline
- Start date
- 2015-05-20
- Primary completion
- 2017-02-14
- Completion
- 2017-03-10
- First posted
- 2014-12-18
- Last updated
- 2017-06-16
Locations
1 site across 1 country: South Korea
Source: ClinicalTrials.gov record NCT02319941. Inclusion in this directory is not an endorsement.